, although the underlying mechanisms are only beginning to be elucidated. Of particular interest is how stem/progenitor cells in self-renewing epithelia are affected by exposure to a chronic inflammatory environment, especially as aberrant stem cell function is associated with diseases linked to chronic inflammation [7] [8] [9] [10] . Previous studies have shown that chronic inflammation can exert a direct effect on epithelial stem/progenitor cells by secreting soluble factors that regulate key signalling cascades controlling stem cell function [11] [12] [13] . However, in addition to regulation by soluble factors such as cytokines and growth factors, stem cells are also regulated by a variety of other microenvironmental cues. In particular, the mechanical properties of tissues can profoundly influence cellular responses and can exert a dominant influence on their response to the mileu of extrinsic factors present in the tissue stroma/niche 14, 15 . Mechanical cues, such as elasticity and topography, are heavily influenced by the deposition and organization of extracellular matrix (ECM) proteins [16] [17] [18] [19] , which are secreted by stromal cell types such as tissue-resident fibroblasts 16, 19 . Interestingly, a hallmark of many chronic inflammatory conditions is fibrosis, in which excessive ECM deposition occurs in response to persistent inflammation [20] [21] [22] . This therefore raises the possibility that at least some of the effects of chronic inflammation may be a consequence of altered mechanical cues downstream of fibrosis. Thus, understanding the link between chronic inflammation and tissue mechanical properties may identify new therapeutic targets.
The corneal epithelium (CE), which forms a protective barrier on the anterior ocular surface, is a clinically relevant example of a self-renewing epithelium in which chronic inflammation is closely associated with abnormal function.
The CE is a stratified epithelium that resides on a relatively simple, avascular stroma and which is maintained during homeostasis and repair by corneal epithelial stem cells 23 (CESCs) . At present, the precise identity of CESCs is unknown as stem-cell-specific markers are lacking. However, label-retaining experiments and functional assays indicate that they reside predominantly, although not exclusively, at the limbus, a junctional zone between the cornea and the conjunctiva 24, 25 . Importantly, stem cells isolated from the limbus can be used clinically to reconstitute the corneal epithelium following injury or disease, either by direct transplantation or by grafting in vitro-expanded cultures of limbal stem cells 26 . Chronic inflammation has a profound effect on the function of CESCs, and is associated with poor outcome in limbal transplantation 27 and with conditions such as corneal squamous cell metaplasia (CSCM), in which the CE adopts a keratinizing, skin-like fate [28] [29] [30] . We have previously shown that loss of Notch1 in the mouse CE promotes the development of CSCM specifically during repair 31 . In this model CSCM is induced following remodelling of the underlying corneal stroma by the Notch1-deficient CE and is thus a consequence of changes in the surrounding microenvironment. Interestingly, in other stratified epithelial tissues, such as the skin, Notch signalling has been shown to negatively regulate inflammation 32, 33 , raising the possibility that an aberrant inflammatory response during wound healing may play a role in promoting CSCM in Notch1 mutants. In this study, we have used Notch1 mutant mice as a means to investigate the significance of inflammation during CSCM induction and have specifically explored the link between inflammation and mechanotransduction in mediating cell fate alterations.
RESULTS

Chronic inflammation promotes CSCM
To investigate the role of inflammation in CSCM, we used Notch1 lox/lox :K5Cre ERT mice, in which tamoxifen-induced cre activity results in conditional deletion of Notch1 in the CE (ref. 31) . Consistent with our previous report, the unwounded Notch1-deficient (Notch1 ) cornea maintained corneal identity on the ocular surface, as indicated by the expression of the corneal-specific cytokeratin 12 (K12), and exhibited a simple, relatively acellular stroma, and was thus indistinguishable from wild-type (WT) controls ( Supplementary  Fig. 1a ). However, after repeated injury (Fig. 1a) , Notch1 mice developed corneal opacity and significant morphological changes at the histological level (Fig. 1b) . Specifically, the Notch1 corneal stroma was infiltrated with large numbers of polymorphonuclear neutrophils, indicative of an ongoing inflammatory response, and exhibited CSCM, indicated by expression of the epidermal-specific cytokeratin 1 (K1; Fig. 1b) . In contrast, WT controls did not exhibit any overt signs of inflammation and retained a K12 + K1 − corneal epithelium, although K12 − K1 + cells were present at the limbus (Fig. 1b) . Flow cytometric analysis confirmed that Notch1 corneas contained increased numbers of CD45 + leukocytes both during repair and at least 21 days after injury when wound closure had occurred (Fig. 1c,d) , with most infiltrating CD45 + cells exhibiting a CD11b
+ Gr1 + phenotype ( Supplementary Fig. 1b,c) , indicative of neutrophils. Furthermore, a variety of pro-inflammatory cytokines exhibited significant upregulation in the Notch1 CE compared with WT CE following injury (Fig. 1e) . Collectively, the above findings indicate that CSCM in Notch1 mice is closely associated with an augmented and chronic inflammatory response.
In light of this, we sought to establish whether chronic inflammation is both necessary and sufficient to induce epidermal differentiation on the ocular surface. We therefore employed two approaches. First, we aimed to abrogate the inflammatory response in Notch1 mice to determine whether aberrant inflammation is essential for CSCM in this model. Second, we aimed to establish whether chronic inflammation is sufficient to induce CSCM in a Notch-independent setting.
Regarding the former, we noted that many of the pro-inflammatory cytokines upregulated in the Notch1 CE are targets of the transcription factor AP-1. Furthermore, the Notch1 CE exhibited increased phosphorylation of the AP-1 family member cjun at Ser 73, indicative of activation ( Supplementary Fig. 2a ). We therefore reasoned that persistent AP-1 activation in the Notch1 CE contributes to the chronic inflammatory response in Notch1 mice, consistent with previous reports [34] [35] [36] . We therefore generated Notch1 lox/lox :cjun lox/lox :K5Cre ERT mice and simultaneously ablated Notch1 and cjun by tamoxifen treatment (Notch1 :cjun ). Following injury, Notch1 :cjun mice exhibited a significantly reduced inflammatory response compared with Notch1 mutants despite Notch1 ablation ( Supplementary Fig. 2b -e) and strikingly retained a K12
+ K1 − CE after repeated injury ( Supplementary Fig. 2f-h ), supporting the hypothesis that chronic inflammation is essential for the development of CSCM in Notch1 mice.
An important caveat to the experiments using the Notch1 :cjun mice is that AP-1 regulates a variety of cellular functions in addition to inflammation, including differentiation 34, 37, 38 , and thus an autonomous effect cannot be ruled out. Therefore, to definitively establish that inflammation is the key driver of CSCM in Notch1 mice, we administered a dexamethasone-based anti-inflammatory gel (Tobradex) to the ocular surface during the repeated injury procedure (Fig. 2a) . Strikingly, Notch1 mice treated with Tobradex exhibited a relatively normal corneal stroma and maintained a K12 + K1 − CE (Fig. 2b) , despite Notch1 ablation ( Supplementary Fig. 2i ), thus confirming that chronic inflammation is essential for CSCM in Notch1 mutants.
To establish whether chronic inflammation is sufficient for the induction of CSCM in a Notch-independent setting, we performed the repeated injury procedure on K14TSLPTg mice 39 , which develop chronic inflammation in stratified epithelia due to the expression of the pro-inflammatory cytokine TSLP (ref. 40 ; Fig. 2c ). Strikingly, K14TSLPTg mice exhibited a near identical phenotype to Notch1 mutants (Fig. 2d) , confirming that chronic inflammation is indeed sufficient for the induction of CSCM.
CSCM is induced in activated stem/progenitor cells located at the limbus and peripheral cornea
We next sought to address the cellular and molecular mechanism by which chronic inflammation promotes aberrant cell fate and to this end used Notch1 mice as a model of inflammation-associated CSCM.
Initially, we determined the spatial and temporal kinetics of CSCM development in Notch1 mice. Whole-mount immunofluorescence on CE isolated after each injury-repair cycle demonstrated that CSCM first became apparent after the second injury ( Supplementary Fig. 3a ). This was characterized by the presence of K12 − K1 + cells within the Notch1 CE, particularly at the peripheral cornea in close proximity to the limbus ( Supplementary Fig. 3a ). In contrast, WT CE remained K12 + K1 − , although K12 − K1 + epidermal cells were present in the limbus to varying degrees ( Supplementary Fig. 3a) .
We therefore chose to analyse the second injury-repair cycle at 0, 6 and 24 h after injury, to determine when and where CSCM is induced. In WT controls, K12
+ K1 − cells predominated throughout the CE biological replicates for each genotype over three independent experiments; each replicate consists of cells pooled from 4 corneas isolated from 2 mice of each genotype). (e) QRT-PCR analysis for the indicated cytokines in WT (Notch1 lox/lox ) and Notch1 corneal epithelial cells 24 h after a single corneal injury. Data are expressed relative to the expression in WT unwounded corneal epithelial cells (n = 6 biological replicates for each genotype over three independent experiments; each replicate consists of corneal epithelial tissue pooled from 6 corneas isolated from 3 mice of each genotype). Scale bars represent 500 µm on tiled images and 5 µm on all other histological images. Scale bars on images showing gross morphology of corneas represent 1 mm. Black and white dotted lines indicate the boundary between the stroma and epithelium. St, stroma. * P < 0.01, * * P < 0.05 (unpaired, two-tailed t-tests). Error bars represent standard deviation.
at each stage of repair, although K12 − K1 + cells were present in the limbus (Fig. 3a,b) , consistent with the observations from whole-mount analysis ( Supplementary Fig. 3a) . In contrast, Notch1 mice exhibited increasingly prominent areas of K12 − K1 + cells extending from the limbus into the peripheral cornea as wound healing progressed (Fig. 3a,b) . In addition, the epithelium in the limbus and peripheral cornea of Notch1 mice was generally less stratified than in WT controls (Fig. 3a) . Consistent with the whole-mount analysis, no overt phenotypic differences were apparent between WT and Notch1 CE during the first injury-repair cycle ( Supplementary Fig. 3b) .
The above findings indicate that CSCM in Notch1 mice is initially induced at the limbus/peripheral cornea and subsequently migrates to the site of injury as wound closure proceeds. This is consistent with the model of corneal regeneration proposed in a previous study, which found that cells mediating wound healing are derived from stem/progenitors located in the limbus 25 . In support of this, we observed increased proliferative activity in the limbus and peripheral cornea following injury ( Supplementary  Fig. 3c,d ), suggesting activation of stem/progenitor cells specifically within these regions. In addition, whole-mount immunofluorescence on CE isolated after repeated injury revealed that metaplastic K12
− K1 + regions in Notch1 CE remained continuous with the limbus/peripheral cornea, and thus conformed to the pattern expected if CSCM derived from this region (Fig. 3c,d ).
Chronic inflammation induces CSCM through elevation of β-catenin signalling in the CE
At the molecular level, aberrant Wnt/β-catenin signalling has been linked to squamous cell metaplasia in a variety of epithelial tissues, including the cornea [41] [42] [43] , and is therefore a good candidate for mediating CSCM in response to chronic inflammation. Consistent with this, the Notch1 CE exhibited increased expression of β-catenin following induction of CSCM by repeated injury (Fig. 4a) . To determine whether increased β-catenin expression overlapped with CSCM induction, we quantified its expression during each injury-repair cycle. In unwounded corneas and during the first injury-repair cycle, β-catenin expression was relatively high in the limbus but declined in the peripheral and central CE in WT and Notch1 mice ( Supplementary Fig. 4a,b) . However, following the second injury, high β-catenin expression was evident throughout the Notch1 CE (Fig. 4b,c) . In WT controls, β-catenin expression was increased in the limbus, but again declined in the peripheral and central CE (Fig. 4b,c) . Thus, high β-catenin expression overlapped spatially and temporally with the presence of K12 − K1 + epidermal cells.
To definitively establish whether β-catenin is the molecular factor that induces CSCM, we performed loss-and gain-offunction experiments in vivo. Thus, to determine whether β-catenin is necessary for CSCM induction, tamoxifen-treated Notch1 lox/lox :Ctnnb1 lox/lox :K5Cre ERT mice, in which Notch1 and Ctnnb1 (β-catenin) are simultaneously ablated in the CE (Notch1 :Ctnnb1 ), were subjected to repeated corneal injury (Fig. 4d) . This resulted in chronic inflammation in the corneal stroma in a similar manner to Notch1 mutants (Fig. 4e) . However, β-catenin-deficient cells Notch1 :Ctnnb1 Ex3 corneas over four independent experiments. Large panels are low magnification tiled images. White outlined insets are high-magnification images of the indicated regions. Scale bars represent 500 µm on tiled images and 5 µm on all other images. White dotted lines indicate the boundary between the stroma and epithelium. St, stroma; NS, not significant. * P < 0.01, * * P < 0.05 (unpaired, two-tailed t-tests). Error bars represent standard deviation.
retained a predominantly K12
+ K1 − phenotype, even in the presence of a chronic inflammatory environment, although the epithelium remained hyperplastic (Fig. 4e, Supplementary Fig. 4c ). Thus, elevated β-catenin signalling in corneal epithelial cells is essential for inflammation-induced CSCM.
In the reciprocal gain-of-function experiment, we induced constitutive activation of β-catenin in the CE using tamoxifentreated Ctnnb1 lox(ex3)/lox(ex3) :K5Cre ERT mice 44 (hereafter referred to as Ctnnb1 Ex3 mice), in which β-catenin is stabilized owing to cremediated excision of the degradation domain within exon 3. After a single injury-repair cycle (Fig. 4f) , Ctnnb1
Ex3 mice exhibited epidermal differentiation on the ocular surface, in contrast to WT controls that, as expected, maintained a corneal phenotype (Fig. 4g) . In this system, there was no evidence of chronic inflammation, as the presence of CD45
+ cells in the Ctnnb1 Ex3 stroma seemed equivalent to WT controls (Fig. 4g) . Furthermore, the induction of epidermal differentiation correlated strictly with elevated β-catenin expression (Supplementary Fig. 4d ). Together, these data strongly suggest that overexpression of β-catenin is sufficient for the cell-autonomous induction of CSCM. In addition, whole-mount immunofluorescence demonstrated that regions of CSCM in Ctnnb1 Ex3 cornea remained continuous with the limbus/peripheral cornea ( Supplementary Fig. 4e) , thus supporting the hypothesis that CSCM is induced at this location.
Chronic inflammation is associated with excessive ECM deposition, increased tissue stiffness and elevated mechanotransduction in the CE We next addressed the mechanism by which chronic inflammation elicits elevated β-catenin in the CE. Surprisingly, we could not find any evidence of increased Wnt ligand expression in the Values for expression levels are relative values normalized to the expression level in the conjunctival stroma of each sample, determined by mean fluorescence intensity. n = 6 corneas for each genotype at each time point over three independent experiments. Scale bars on tiled images represent 500 µm. NS, not significant. * P < 0.01, * * P < 0.05 (unpaired, two-tailed t-tests). Error bars represent standard deviation.
Notch1 cornea (Supplementary Fig. 5a ), suggesting that the chronic inflammatory environment does not activate the Wnt signalling cascade. Previous studies have linked mechanotransduction to the induction of β-catenin activity in epithelia 15 . The mechanisms underlying mechanotransduction remain to be fully elucidated, although YAP/TAZ have recently emerged as primary cellular sensors of tissue mechanical cues 14, 45 . Intriguingly, a recent report has shown that YAP/TAZ directly regulate β-catenin expression by forming an integral part of the cytoplasmic β-catenin destruction complex. According to the proposed model, removal of YAP/TAZ from the destruction complex, through mechanically induced nuclear translocation, increases β-catenin expression owing to impaired degradation 46 . We therefore speculated that chronic inflammation may induce aberrant mechanotransduction in the CE by causing changes in the mechanical properties of the corneal stroma, for example through excessive deposition of ECM, as occurs in fibrosis 47 . This would therefore result in nuclear localization of YAP/TAZ and increased β-catenin expression.
To determine whether increased ECM deposition was associated with CSCM, the expression of the ECM proteins periostin and tenascin C, which are linked to fibrosis 48, 49 , was analysed during each injury-repair cycle. In WT corneas, both periostin and tenascin C were restricted to the stroma underlying the limbus at each stage ( Fig. 5a-d) . A similar pattern was observed in unwounded Notch1 corneas and in Notch1 corneas during the first injuryrepair cycle (Fig. 5a-d) . However, expression in the peripheral and central corneal stroma of Notch1 mutants increased markedly during the second injury-repair cycle ( Fig. 5a-d) . In support of a fibrotic-like response, the expression of periostin and tenascin C was largely restricted to non-haematopoietic cell types ( Supplementary  Fig. 5b ). Furthermore, abrogation of inflammation in Notch1 mice by Tobradex treatment resulted in reduced ECM deposition in the corneal stroma ( Supplementary Fig. 5c ), indicating that the effect occurred downstream of inflammation.
ECM deposition in the corneal stroma also correlated with activation of mechanotransduction in the overlying CE after the second injury, as demonstrated by increased phosphorylation of focal adhesion kinase (pFAK), and increased nuclear localization of Rho coiled-coil kinase 2 (ROCK2) and YAP/TAZ (Fig. 6a-g ). Importantly, in unwounded corneas and in corneas isolated after the first injury, mechanotransduction was restricted to the ECMrich limbus and was not apparent in the CE ( Supplementary  Fig. 6a,b) . Furthermore, abrogation of inflammation in Notch1 mice by Tobradex treatment reduced mechanotransduction in the corneal epithelium (Supplementary Fig. 6c ). Thus, in a similar manner to β-catenin, there was a spatial and temporal overlap between increased ECM deposition, mechanotransduction and CSCM induction.
To gather additional evidence of a role for mechanotransduction, we determined whether ECM deposition resulted in changes in the mechanical properties of the corneal stroma by employing atomic force microscopy in combination with immunofluorescence. This enabled us to correlate the expression of ECM with tissue stiffness and revealed that increased expression of tenascin C in Notch1 corneas correlated with increased stiffness of the corneal stroma compared with WT controls, an effect that was apparent at the limbus, peripheral CE and central CE (Fig. 7a,b) .
In light of the above data, we sought to establish a functional link between mechanotransduction and β-catenin signalling. We therefore obtained primary cultures of pig corneal epithelial stem cells (PCESCs), which can be readily cultivated in vitro, and determined the effect of mechanical stimuli by growing these cells on stiff versus soft substrates. Importantly, in this assay, PCESCs were cultured in the absence of feeder cells to promote differentiation. Strikingly, cells grown on stiff substrates expressed higher levels of β-catenin compared with cells grown on soft substrates, as well as exhibiting increased nuclear localization of YAP/TAZ and perturbed differentiation (Fig. 7c-g ). Moreover, PCESCs cultured on extremely stiff substrates (glass) in the presence of the ROCK inhibitor Y27632 expressed lower levels of β-catenin, exhibited reduced nuclear localization of YAP/TAZ and exhibited a higher propensity for corneal differentiation compared with cells maintained in vehicle ( Supplementary Fig. 7a-e) .
Further evidence of a link between mechanotransduction and β-catenin signalling was provided by induction of TCF-luciferase activity in reporter cells following expression of a constitutively active ROCK2 kinase domain ( Supplementary Fig. 7f-h ), indicating that forced activation of the mechanotransduction cascade does indeed activate β-catenin signalling.
Collectively, these data support the hypothesis that activation of mechanotransduction is sufficient to promote elevated β-catenin activity in corneal epithelial cells and, in addition, suggest that this is a mechanism that is conserved across species.
Modulation of mechanotransduction cascades regulates cell fate on the ocular surface
To definitively establish that chronic inflammation promotes CSCM through mechanotransduction, we tested whether manipulation of the mechanotransduction cascade affects cell fate on the ocular surface in vivo. In the first instance, we determined whether inhibition of mechanotransduction could restore corneal differentiation in chronically inflamed Notch1 corneas by using small-molecule inhibitors of FAK (PF562271) or ROCK (Y27632; Fig. 8a ). Strikingly, mice treated with either inhibitor retained a predominantly K12 + K1 − CE, despite the presence of a chronically inflamed stroma (Fig. 8b-e) , thus supporting the hypothesis that chronic inflammation elicits CSCM through activation of mechanotransduction. To test the hypothesis further, we performed the reciprocal experiment by ablating YAP/TAZ from the CE, thus removing cytoplasmic YAP/TAZ and recapitulating the effect of mechanotransduction. Thus, tamoxifen-treated Yap lox/lox :Taz lox/lox :K14Cre ER mice, in which YAP and TAZ are ablated in the CE (YAP :TAZ ), were subjected to a single corneal injury and analysed 7 days later (Fig. 8f) . Strikingly, the ocular surface of YAP :TAZ corneas exhibited overt epidermal differentiation, particularly in peripheral regions (Fig. 8g) , which correlated with loss of YAP/TAZ (Fig. 8h) and increased β-catenin expression (Fig. 8i) . As expected, WT controls maintained corneal identity throughout the CE (Fig. 8g-i) .
Collectively, these data provide functional evidence that chronic inflammation induces CSCM by activating the mechanotransduction cascade.
DISCUSSION
In this study we have demonstrated that a central mechanism by which chronic inflammation can promote aberrant cell fate is through mechanotransduction (Fig. 8j) . The data presented support a model whereby exposure of the corneal stroma to chronic inflammation results in the induction of excessive ECM deposition, which subsequently promotes epidermal differentiation in the regenerating epithelium through mechanical induction of β-catenin signalling. Values for expression levels are relative values normalized to the expression level in the conjunctiva of each sample, determined by mean fluorescence intensity. Black bars, WT (Notch1 lox/lox ); grey bars, Notch1 (n = 6 corneas for each genotype over three independent experiments). (f,g) Quantification of nuclear/cytoplasmic ratio (N/C) of ROCK2 (f) and YAP/TAZ (g) in the limbus, peripheral cornea and central cornea 24 h after the second injury. n = 6 corneas for each genotype over three independent experiments. St, stroma; NS, not significant. * P < 0.01, * * P < 0.05 (unpaired, two-tailed t-tests). Error bars represent standard deviation. Scale bars represent 5 µm. White dotted lines indicate the boundary between the stroma and epithelium.
The mechanisms underlying ECM deposition in this model remain to be fully elucidated, although the expression of matrix components is confined to non-haematopoietic stromal cells, thus suggesting that the changes in the ECM occur owing to a fibrotic-like process. A variety of immune cells, including macrophages 50 , neutrophils 51 and T cells 52 , are linked to the induction of fibrosis through the secretion of cytokines such as TGF-β (refs 53,54) and IL-13 (refs 22,55) , which subsequently induce excessive ECM deposition by α-SMA + myofibroblasts [56] [57] [58] . It will thus be interesting to determine whether similar cellular and molecular mechanisms are involved in the stromal remodelling observed in the chronically inflamed cornea. The profiles of inflammatory cell types in the corneal stroma of both WT and Notch1 mice are similar following injury and consist predominantly of CD11b + Gr1 + neutrophils, although the magnitude of the response is elevated in Notch1 mice. However, the prolonged duration of the inflammatory response in Notch1 mutants seems to be critical for the induction of stromal remodelling and resulting metaplasia, as both of these effects occur following repeated cycles of injury and repair. Experiments in which specific inflammatory cell types and cytokines can be efficiently depleted will enable delineation of the specific cellular and molecular mediators involved and may identify promising targets for therapeutic intervention in ocular surface disorders.
The induction of CSCM in the model described here is initially induced in the limbus and peripheral corneal epithelium, locations (e-g) Quantification of β-catenin expression (MFI, mean fluorescence intensity) (e), YAP/TAZ nuclear/cytoplasmic ratio (N/C) (f) and the proportion of K12 + K1 − and K12 − K1 + cells (g) in PCESCs cultured on soft or stiff substrates (n = 6 for each condition over 2 independent experiments, where one replicate represents quantification from a single culture). For e, β-catenin expression is determined by mean fluorescence intensity. Scale bars in a represent 15 µm; scale bars in c and d represent 20 µm. * P < 0.01, * * * P < 0.1 (unpaired, two-tailed t-tests). Error bars represent standard deviation (e-g) or maximal values/1.5× interquartile range (b).
that contain significant numbers of activated stem/progenitor cells following injury. In addition, it is notable that although there is a significant overlap between elevated β-catenin expression and CSCM, not all β-catenin hi cells undergo epidermal fate conversion. This therefore suggests that only a proportion of epithelial cells on the anterior ocular surface are permissive to β-catenin-induced fate switching. Given that the induction of CSCM coincides temporally and spatially with the activation of stem/progenitor cells in the limbus and peripheral cornea, it is tempting to speculate that these cells represent uncommitted progenitor cells that retain the potency to form epidermis in response to elevated β-catenin. To formally prove this hypothesis, phenotypic markers that precisely identify stem and progenitor cells in the corneal epithelium are required to definitively establish the cellular target of β-catenin-induced CSCM. Finally, although this study demonstrates that mechanotransduction is a key mechanism by which chronic inflammation can impose aberrant cell fate, the mechanisms by which inflammation influences other aspects of stem/progenitor cell function are likely to be multifaceted. Notably, although inhibition of mechanotransduction and/or β-catenin signalling restores corneal identity in a chronic inflammatory environment, the epithelium remains hyperplastic. Thus, inflammation is likely to effect traits such as cell fate and proliferation through distinct mechanisms.
In summary, our findings demonstrate that chronic inflammation can promote aberrant cell fate through mechanotransduction and thus reveal an important mechanism by which aberrant inflammatory responses can promote the development of disease.
METHODS
Methods and any associated references are available in the online version of the paper.
Note: Supplementary Information is available in the online version of the paper
Ethics statement. All animal work was conducted in accordance with Swiss national guidelines. All mice were kept in the animal facility under EPFL animal care regulations. They were housed in individual cages at 23 • C ± 1 • C with a 12 h light/dark cycle. All animals were supplied with food and water ad libitum. This study has been reviewed and approved by the Service Veterinaire Cantonal of Etat de Vaud.
Mice. Notch1
lox/lox , Ctnnb1 lox/lox and K5Cre ERT mice were as previously described [59] [60] [61] and were maintained on a C57BL/6 background. cjun lox/lox mice were as previously described 62 and were provided by E.F.W. Yap lox/lox :Taz lox/lox :K14Cre ER were as previously described 5 provided by S.P. These mice were backcrossed onto the C57BL/6 background. Ctnnb1 lox(ex3) and K14TSLPTg mice were as previously described 6, 7 and were maintained on an sv129 background. were generated by performing the required inter-crosses and were maintained as homozygotes. For conditional ablation of YAP/TAZ, Yap lox/lox :Taz lox/lox :K14Cre ER mice were administered with 1 mg tamoxifen once a day for 3 days by intraperitoneal injection. For all other gene activation/inactivation experiments, tamoxifen dissolved in peanut oil was administered once a day for 5 consecutive days by intraperitoneal injection at a dose of 50 mg kg −1 . For each experiment, all mice were age matched and were between 4 and 7 weeks of age. Male and female animals were used. All mouse experiments were non-randomized and non-blinded; a minimum of three animals were used for each experiment, allowing a minimum of six corneas to be analysed for each experiment. This number was deemed sufficiently appropriate to account for normal variation, as determined from previous studies. Numbers of animals for each experiment are described in the figure legends. No statistical method was used to predetermine sample size.
Statistical analysis. For statistical analysis, unpaired two-tailed t-tests were performed on normally distributed data sets with equal variance assumed. Unless otherwise stated, n numbers for experiments stating statistical significance represent biological replicates. Sample size in all cases was a minimum of 6 independent biological replicates, according to availability of biological material.
Corneal wounding. Mice were anaesthetized by sub-cutaneous injection of ketamine (100 mg kg −1 ) and xylazine (10 mg kg −1 ). Anaesthetic collrium (0.4% oxybuprocaine) was applied to the ocular surface to prevent corneal reflex.
To wound the ocular surface, a circular area 2 mm in diameter was marked on the central cornea by gentle application of a 2 mm biopsy punch. Removal of the epithelial tissue within this area was then achieved using a Demarres spatula (Moria Surgical) with a 45 • cutting angle. The efficiency of wounding was monitored by application of 0.5% solution of ophthalmic fluorescein (Novartis). Following corneal wounding, Viscotears ophthalmic gel (Novartis) was applied to the ocular surface.
On waking, mice were administered with 0.3 ml 0.9% NaCl solution (Braun) to aid recovery. Dafalgen analgesic was provided in the drinking water following corneal wounding at a concentration of 2 mg ml −1 .
Administration of Tobradex anti-inflammatory gel. Tobradex gel or ophthalmic lubricating gel was administered topically to the ocular surface once a day throughout the corneal wounding procedure, starting from the day of the first corneal wound and ending 21 days after the third corneal wound.
Administration of PF562271 (FAK inhibitor) and Y27632 (ROCK inhibitor).
For systemic administration, PF562271 (Selleckchem) was dissolved in 70% DMSO/dH2O and injected i.p. at a dose of 30 mg kg −1 every other day for 14 days following the final corneal injury. Control mice were injected with 70% DMSO vehicle alone. For topical application, a 3 µl drop of 10 mM PF562271 was applied to the ocular surface twice a day for 14 days following the final corneal injury in a 15% DMSO solution (diluted in dH20). Control mice were administered with 15% DMSO vehicle alone.
For systemic administration, Y27632 (Sigma) was dissolved in saline solution and injected i.p. at a dose of 30 mg kg −1 every other day for 14 days following the final corneal injury. Control mice were injected with saline vehicle alone.
For topical application, a 3 µl drop of 10 mM Y27632 diluted in saline was applied to the ocular surface twice a day for 14 days following the final corneal injury. Control mice were administered with saline vehicle alone.
Cell culture. Peripheral corneal epithelial cells were isolated from porcine corneas and cultivated on lethally irradiated 3T3-J2 feeder cells in 3:1 DMEM/F12 medium supplemented as previously described 63 . For experiments analysing the effect of substrate stiffness, cells were plated on glass coverslips, standard tissue culture plastic, 15% PEG or 2.5% PEG hydrogels in the absence of 3T3-J2 feeders at a density of 50,000 cells cm −2 . For experiments using the ROCK inhibitor Y27632, cells were seeded onto glass coverslips in the absence of 3T3-J2 feeders at a density of 50,000 cells cm −2 . All substrates in feeder-free cultures were coated with recombinant human collagen I (AteloCell). Glass coverslips were treated with poly-L-lysine (Sigma) before collagen coating.
Hydrogel substrates were formed by crosslinking two branched PEG precursors of relative molecular mass 10,000, end-functionalized with either thiol (TH) or vinylsulphone (VS) groups (NOF Corporation). To adjust the stiffness the precursors were mixed at different mass to volume ratios. Fifty microlitres of the mixed hydrogel precursor solution were transferred to each well of a 12-well plate (Falcon). A hydrophobic PDMS stamp with spacers was used to produce homogeneous and thin gel layers. The partially crosslinked hydrogel substrate was subsequently functionalized with Collagen I (AteloCell) under pressure for 2 h. The functionalized hydrogel layers were then washed with PBS and ultraviolet-sterilized.
Transient transfection of porcine corneal epithelial cells was performed using JetPEI transfection reagent (PolyPlus) according to the manufacturer's instructions.
TCF-Luc 293T cells were maintained in DMEM supplemented with 10% FCS.
TCF-luciferase reporter assay. 293T cells with a stably integrated luciferase cassette containing upstream TCF-binding sites were a kind gift from J. Huelsken. To assay TCF-luciferase activity in the presence or absence of the murine ROCK2 kinase domain, TCF-Luc 293T cells were transiently co-transfected with pR2KD/pRenilla or pEGFP/pRenilla using JetPEI (PolyPlus) transfection reagent according to the manufacturer's instructions. Luciferase activity was subsequently analysed 36-48 h later using the Dual-Luciferase Reporter Assay System (Promega) and a Berthold Lumat Luminometer. Luciferase values were normalized to Renilla-luciferase values.
Preparation of corneal single-cell suspensions and flow cytometry. Whole corneal tissue was isolated from murine eyes, placed in ice-cold PBS and cut into small fragments using a scalpel blade. Corneal fragments were then digested in 2 mg ml PCR was performed using Q5 DNA polymerase (NEB) according to the manufacturer's instructions, with the addition of DMSO to a final concentration of 5%. Amplified fragments were cloned using the TOPO TA cloning system (Invitrogen).
The 5 and 3 fragments were inserted into an expression vector (pI-EGFP2) downstream of a CMV promoter/enhancer and upstream of an IRESEGFP cassette through a three-way ligation using SalI, NcoI (present in the overlapping region of each fragment) and Not-I restriction sites, resulting in the generation of pR2KD.
Tissue processing for histology. Fresh frozen and paraffin-embedded tissues were used for histological analysis. For fresh frozen tissue, whole eyes were embedded in OCT compound (TissueTek) using standard protocols. Eight-micrometre-thick sections were cut using a Leica CM1850 cryostat. Cryosections were stored at −80 • C.
